share_log

Short Interest in THC Biomed Intl Ltd. (OTCMKTS:THCBF) Rises By 135.1%

kopsource ·  Dec 29, 2022 12:01

THC Biomed Intl Ltd. (OTCMKTS:THCBF – Get Rating) was the recipient of a significant growth in short interest in December. As of December 15th, there was short interest totalling 56,200 shares, a growth of 135.1% from the November 30th total of 23,900 shares. Based on an average daily trading volume, of 54,000 shares, the short-interest ratio is presently 1.0 days.

THC Biomed Intl Stock Performance

OTCMKTS THCBF traded down $0.01 during mid-day trading on Wednesday, reaching $0.02. 15,879 shares of the stock were exchanged, compared to its average volume of 19,111. The business's 50 day moving average is $0.02 and its 200-day moving average is $0.03. THC Biomed Intl has a 1 year low of $0.01 and a 1 year high of $0.08.

Get THC Biomed Intl alerts:

About THC Biomed Intl

(Get Rating)

THC Biomed Intl Ltd. produces and sells medical and recreational cannabis in Canada. It offers cannabis beverage shots, gummies, and biscuits under the THC KISS brand names, as well as pure cannabis sticks. THC Biomed Intl Ltd. was founded in 2012 and is headquartered in Kelowna, Canada.

Read More

  • Get a free copy of the StockNews.com research report on THC Biomed Intl (THCBF)
  • The Top Three Stocks Analysts Say To Buy
  • Can Dick's Sporting Goods Stock Score Another Win In Q4?
  • Yum! Brands Looks Tasty in 2023
  • Why Did Immutep Ltd Stock Soar Recently?
  • 3 Industrial Stocks to Help Build Your 2023 Watchlist

Receive News & Ratings for THC Biomed Intl Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for THC Biomed Intl and related companies with MarketBeat.com's FREE daily email newsletter.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment